<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>High levels of B-type natriuretic <z:chebi fb="7" ids="16670">peptide</z:chebi> (BNP), a serum marker of <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, are associated with an increased risk for <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, no study has yet assessed this marker in different subtypes of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the hypothesis that BNP has a more significant association with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> than <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma BNP was measured in 15 patients with subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, in 19 Alzheimer patients without evidence of vascular comorbidity, and in age-matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>Compared with controls (28+/-7 ng/l), BNP was elevated in subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (63+/-17 ng/l; P=0.03), but not in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (36+/-5 ng/l) </plain></SENT>
<SENT sid="5" pm="."><plain>In conclusion, subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> is indeed associated with moderately elevated BNP levels, whereas this could not be shown for <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>This probably reflects the larger cardiovascular burden in patients with subcortical vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>